PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION, CONTAINING IMMUNOLOGICAL PHARMACEUTICAL PREPARATION

摘要

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of cerebral infarction, administrable even to a patient after cerebral infarction acute stage passage.;SOLUTION: The pharmaceutical composition for the treatment of cerebral infarction comprises a thrombolytic agent and a binding inhibitor for inhibiting the binding of a vascular endothelial growth factor (VEGF) to a receptor of the VEGF. The pharmaceutical composition for the treatment of cerebral infarction is, if necessary, administered to patients after cerebral infarction acute stage passage. The pharmaceutical composition for the treatment of cerebral infarction, if necessary, contains tissue type plasminogen-activator (t-PA) or a derivative thereof. The pharmaceutical composition for the treatment of cerebral infarction, if necessary, contains an anti-VEGF-A neutralizing antibody or a derivative thereof.;COPYRIGHT: (C)2015,JPO&INPIT